Serum level of interleukin-33 in rheumatoid arthritis patients and its association with bone erosion and interstitial lung disease

Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, 23, 479, 10.1016/j.immuni.2005.09.015 Hassan, 2011, Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity, Int J Rheum Dis, 14, 325, 10.1111/j.1756-185X.2011.01630.x Gheita, 2012, Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study, Phytother Res, 26, 1246, 10.1002/ptr.3679 Gheita, 2014, Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren’s Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome, Mod Rheumatol, 24, 612, 10.3109/14397595.2013.851639 Al-Zifzaf, 2015, FoxP3+T regulatory cells in rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis, Egypt Rheumatol, 37, 7, 10.1016/j.ejr.2014.06.004 Gheita, 2015, Clinical significance of serum TNFα and -308 G/A promoter polymorphism in rheumatoid arthritis, Egypt Rheumatol, 37, 49, 10.1016/j.ejr.2014.07.001 Helal, 2012, Fatigue in rheumatoid arthritis and its relation to interleukin-6 serum level, Egypt Rheumatol, 34, 153, 10.1016/j.ejr.2012.08.004 Matsuyama, 2010, Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis, J Rheum, 37, 18, 10.3899/jrheum.090492 Xu, 2008, IL-33 exacerbates antigen-induced arthritis by activating mast cells, Proc Natl Acad Sci USA, 105, 10913, 10.1073/pnas.0801898105 Palmer, 2009, Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis, Arthritis Rheum, 60, 738, 10.1002/art.24305 Pastorelli, 2010, Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis, Proc Natl Acad Sci USA, 107, 8017, 10.1073/pnas.0912678107 Chen, 2012, Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice, J Mol Med, 90, 1505, 10.1007/s00109-012-0938-4 Leung, 2004, A novel therapy of murine collagen-induced arthritis with soluble T1/ST2, J Immunol, 173, 145, 10.4049/jimmunol.173.1.145 Duan, 2013, The role of IL-33 in rheumatic diseases, Clin Develop Immunol, 1 Rajasekaran, 2006, Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5years, J Rheumatol, 33, 1250 Burghardt, 2007, A local adaptive threshold strategy for high resolution peripheral quantitative computed tomography of trabecular bone, Ann Biomed Eng, 35, 1678, 10.1007/s10439-007-9344-4 Aletaha, 2010, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Wolfe, 2000, A reappraisal of HAQ disability in rheumatoid arthritis, Arthritis Rheum, 43, 2751, 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6 Døhn, 2008, Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography, Arthritis Res Ther, 10, 45, 10.1186/ar2378 Xu, 2013, IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy, Human Immunol, 74, 1057, 10.1016/j.humimm.2013.06.029 Yuan, 2011, IL-33: a promising therapeutic target for rheumatoid arthritis?, Expert Opin Ther Targets, 15, 529, 10.1517/14728222.2011.560838 Matsuyama, 2012, Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response, Rheumatol Int, 32, 1397, 10.1007/s00296-011-1854-6 Mu, 2010, Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis, J Rheumatol, 37, 2006, 10.3899/jrheum.100184 Xiangyang, 2012, Increased levels of interleukin 33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis, Cytokine, 58, 6, 10.1016/j.cyto.2011.12.010 Ahlmén, 2006, Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage, Ann Rheum Dis, 69, 230, 10.1136/ard.2008.102244 Stach, 2010, Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography, Arthritis Rheum, 62, 330 Bukhari, 2002, Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort, Arthritis Rheum, 46, 906, 10.1002/art.10167 Mun, 2010, Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes, Cell Mol Life Sci, 67, 3883, 10.1007/s00018-010-0410-y Yasuda, 2012, Contribution of IL-33-activated typeII innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice, Proc Natl Acad Sci USA, 109, 3451, 10.1073/pnas.1201042109